Pfizer: Pivotal Phase III Trial Data Show Pfizer's Sasanlimab with BCG Significantly Improves Event-Free Survival in Bladder Cancer
In the pivotal CREST clinical trial, sasanlimab in combination with Bacillus Calmette-Guérin met the primary endpoint of event-free survival.
Read full article »
Pfizer is a New York-based pharmaceutical company that develops and commercializes medicines and vaccines for the healthcare industry.
Read more